Amneal Pharmaceuticals has named Robert Stewart as president, effective January 25, 2018. Stewart was most recently COO at Allergan. Stewart will work with Chirag and Chintu Patel to lead the company’s current business, as well as play a key role in overseeing pre-integration planning for the planned Impax combination, expected to close in the first half of 2018. Once Amneal’s acquisition of Impax closes, Stewart will become president and CEO of the combined Amneal Pharmaceuticals. Also after the close, Impax president and CEO Paul Bisaro will be named executive chairman, with current Amneal co-CEOs and co-founders Chirag Patel and Chintu Patel assuming the titles of co-chairmen of the combined company’s board of directors.